Wells Fargo cuts Amrize to equal-weight, PT to $44
Wells Fargo downgraded Amrize to equal-weight from overweight and cut its price target to $44.00 per share from $55.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.